Christine Reynolds

Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P‐Glycoprotein in the Disposition of Aliskiren

Sujata Vaidyanathan, Gian Camenisch, Helmut Schuetz et al. · The Journal of Clinical Pharmacology · 2008 · 103 citations

Medicine, Pharmacokinetics, Pharmacology +13

Influence of hepatic impairment on everolimus pharmacokinetics: Implications for dose adjustment

John M. Kovarik, Helene D. Sabia, Joaquim Figueiredo et al. · Clinical Pharmacology & Therapeutics · 2001 · 95 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics of Lumiracoxib in Plasma and Synovial Fluid

Graham Scott, Christiane Rordorf, Christine Reynolds et al. · Clinical Pharmacokinetics · 2004 · 59 citations

Medicine, Pharmacokinetics, Pharmacology +8

Pharmacokinetics, Safety, and Tolerability of the Novel Oral Direct Renin Inhibitor Aliskiren in Elderly Healthy Subjects

Sujata Vaidyanathan, Christine Reynolds, Ching‐Ming Yeh et al. · The Journal of Clinical Pharmacology · 2007 · 54 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects

Salim Abdulla, Mbaraka Amuri, Abdunoor M. Kabanywanyi et al. · Malaria Journal · 2010 · 34 citations · Full text

Pharmacy, Pharmacology, Bioavailability +16